Viability and drug sensitivity of M.Leprae isolated from long-term WHO/MDT treated multibacillary leprosy patients

摘要

The ALERT Leprosy Control Programme introduced WHO/MDT in Ethiopia in January 1983. paucibacillary patients are treated for 6 months with self-administered daily dapsone and rifammpicin once monthly under supervision. Multibacillary patients are treated for a period of at least 2 years or until the skin smears become negative. Treatment consists of self-administered dapsone, clofazimine and rifampicin and clofazimine monthly under supervision.